Pharming Group NV banner

Pharming Group NV
F:PHG

Watchlist Manager
Pharming Group NV Logo
Pharming Group NV
F:PHG
Watchlist
Price: 11.3 EUR 0.89% Market Closed
Market Cap: €766.5m

Wall St Price Targets

PHG Price Targets Summary
Pharming Group NV

Wall Street analysts forecast PHG stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for PHG is 23.22 EUR with a low forecast of 18.71 EUR and a high forecast of 28.09 EUR.

Lowest Forecast
Price Target
18.71 EUR
66% Upside
Average Forecast
Price Target
23.22 EUR
106% Upside
Highest Forecast
Price Target
28.09 EUR
149% Upside
Pharming Group NV Competitors:
Price Targets
CENT
Central Garden & Pet Co
12% Upside
ORLY
O'Reilly Automotive Inc
28% Upside
SANA
Sana Biotechnology Inc
176% Upside
SSRM
SSR Mining Inc
69% Upside
TELA
TELA Bio Inc
206% Upside

Revenue
Forecast

41% / Year
Past Growth
20% / Year
Estimated Growth
Estimates Accuracy
-7%
Average Miss
41% / Year
Past Growth
20% / Year
Estimated Growth
Estimates Accuracy
-7%
Average Miss

Over the last 14 years, the compound annual growth rate for Revenue has been 41%. The projected CAGR for the next 5 years is 20%.

Gross Profit
Forecast

49% / Year
Past Growth
0% / Year
Estimated Growth
Estimates Accuracy
-6%
Average Miss
49% / Year
Past Growth
0% / Year
Estimated Growth
Estimates Accuracy
-6%
Average Miss

Over the last 14 years, the compound annual growth rate for Gross Profit has been 49%. The projected CAGR for the next 3 years is 0%.

Operating Income
Forecast

N/A
Past Growth
36% / Year
Estimated Growth
Estimates Accuracy
-16%
Average Miss
N/A
Past Growth
36% / Year
Estimated Growth
Estimates Accuracy
-16%
Average Miss

The compound annual growth rate for Operating Income over the next 5 years is 36%.

Pre-Tax Income
Forecast

N/A
Past Growth
53% / Year
Estimated Growth
Estimates Accuracy
-21%
Average Miss
N/A
Past Growth
53% / Year
Estimated Growth
Estimates Accuracy
-21%
Average Miss

The compound annual growth rate for Pre-Tax Income over the next 3 years is 53%.

Net Income
Forecast

N/A
Past Growth
112% / Year
Estimated Growth
Estimates Accuracy
-12%
Average Miss
N/A
Past Growth
112% / Year
Estimated Growth
Estimates Accuracy
-12%
Average Miss

The compound annual growth rate for Net Income over the next 5 years is 112%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is PHG's stock price target?
Price Target
23.22 EUR

According to Wall Street analysts, the average 1-year price target for PHG is 23.22 EUR with a low forecast of 18.71 EUR and a high forecast of 28.09 EUR.

What is the Revenue forecast for Pharming Group NV?
Projected CAGR
20%

Over the last 14 years, the compound annual growth rate for Revenue has been 41%. The projected CAGR for the next 5 years is 20%.

What is the Gross Profit forecast for Pharming Group NV?
Projected CAGR
0%

Over the last 14 years, the compound annual growth rate for Gross Profit has been 49%. The projected CAGR for the next 3 years is 0%.

What is the Operating Income forecast for Pharming Group NV?
Projected CAGR
36%

The compound annual growth rate for Operating Income over the next 5 years is 36%.

What is the Pre-Tax Income forecast for Pharming Group NV?
Projected CAGR
53%

The compound annual growth rate for Pre-Tax Income over the next 3 years is 53%.

What is the Net Income forecast for Pharming Group NV?
Projected CAGR
112%

The compound annual growth rate for Net Income over the next 5 years is 112%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett